More information: Hélène Guermouche et al, Deciphering Genomic Complexity of Multiple Myeloma Using Optimized Optical Genome Mapping, The Journal of Molecular Diagnostics (2025). DOI: 10.1016/j ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic management of multiple myeloma. This new study in ...

In 58% or 303 of 519 cases, optical genome mapping (OGM) revealed somatic aberrations that were not detected by the standard cytogenetic workup (SCGW), including Tier 1, Tier 2 and Tier 3 ...

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified laboratory developed tests (LDTs ...

Our research shows that integrating OGM into laboratory workflows would enhance prognostic stratification and expand therapeutic options." Reference: Guermouche H, Roynard P, Servoli F, et al.

Dr. Alka Chaubey, chief medical officer at Bionano, will host a sponsored vendor panel presentation on the integration of OGM for clinical research in cancer, featuring cancer genomics experts Dr ...

1. Discuss the reason why microarray, targeted panel , whole exome and even generic whole genome testing might not result in a genetic diagnosis. 2. Discuss how to increase sensitivity of genomic ...

Bionano has completed the early access program for the Stratys™ system and is now making it available in a full commercial releaseThe Stratys instrument can enable up to a four-fold increase in ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic management of multiple myeloma. This new study in ...